{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:18Z","timestamp":1788264978356,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.024","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:09:26Z","timestamp":1787238566000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution"],"prefix":"10.1016","author":[{"given":"Katie","family":"Kubek-Luck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-9966","authenticated-orcid":false,"given":"Jason","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gabriels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bontadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Gilbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9652-7043","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadela","family":"Bouadjemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sigoillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4607-5628","authenticated-orcid":false,"given":"Jan","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-6661","authenticated-orcid":false,"given":"Emily","family":"Meseck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-9663","authenticated-orcid":false,"given":"Eloise","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.024_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.024_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41434-021-00243-z","article-title":"Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions","volume":"28","author":"Riyad","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molmed.2022.01.003","article-title":"AAV capsid design: A Goldilocks challenge","volume":"28","author":"Zolotukhin","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.08.024_bib6","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1073\/pnas.1910061116","article-title":"A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism","volume":"116","author":"Davidsson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.024_bib7","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.024_bib8","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-022-33745-4","article-title":"Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing","volume":"13","author":"Gonzalez","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.024_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","article-title":"Directed evolution of adeno-associated virus for efficient gene delivery to microglia","volume":"19","author":"Lin","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.024_bib10","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.ymthe.2024.12.012","article-title":"Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation","volume":"33","author":"Westhaus","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL\/6J Mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108258","article-title":"Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases","volume":"210","author":"Shamshad","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.ymthe.2026.08.024_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tim.2021.09.005","article-title":"Adeno-associated virus (AAV) cell entry: structural insights","volume":"30","author":"Meyer","year":"2022","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib14","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/JVI.03371-13","article-title":"Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans","volume":"88","author":"Mietzsch","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib16","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1074\/jbc.M110.210922","article-title":"Terminal N-linked galactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.08.024_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.024_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02213-17","article-title":"An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor","volume":"92","author":"Dudek","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ymthe.2019.11.005","article-title":"GPR108 Is a Highly Conserved AAV Entry Factor","volume":"28","author":"Dudek","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.omtm.2020.03.012","article-title":"Pooled Screens Identify GPR108 and TM9SF2 as Host Cell Factors Critical for AAV Transduction","volume":"17","author":"Meisen","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.024_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nmeth1089","article-title":"A probability-based approach for the analysis of large-scale RNAi screens","volume":"4","author":"K\u00f6nig","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.024_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01330-23","article-title":"Identification of host essential factors for recombinant AAV transduction of the polarized human airway epithelium","volume":"97","author":"Hao","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib23","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1038\/s41467-019-11668-x","article-title":"Divergent engagements between adeno-associated viruses with their cellular receptor AAVR","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.024_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.coviro.2017.06.003","article-title":"Host determinants of adeno-associated viral vector entry","volume":"24","author":"Pillay","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01604-20","article-title":"The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction","volume":"94","author":"Madigan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib26","article-title":"AAV2 Bypasses Direct Endosomal Escape by Using AAVR to Access the Trans-Golgi Network en Route to the Nucleus","author":"Cabanes-Creus","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.08.024_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41467-018-02919-4","article-title":"The WDR11 complex facilitates the tethering of AP-1-derived vesicles","volume":"9","author":"Navarro Negredo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.024_bib28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1523\/JNEUROSCI.2584-09.2010","article-title":"BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation","volume":"30","author":"Tramullas","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.08.024_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00018-024-05386-x","article-title":"IER3IP1-mutations cause microcephaly by selective inhibition of ER-Golgi transport","volume":"81","author":"Anitei","year":"2024","journal-title":"Cell Mol. Life Sci"},{"key":"10.1016\/j.ymthe.2026.08.024_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/JVI.01939-15","article-title":"Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo","volume":"90","author":"Zaiss","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/glycob\/cwh118","article-title":"Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopy","volume":"14","author":"Negishi","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2026.08.024_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13861","article-title":"Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells","volume":"140","author":"Merkel","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2026.08.024_bib34","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/bloodadvances.2022008735","article-title":"Individual phosphatidylinositol transfer proteins have distinct functions that do not involve lipid transfer activity","volume":"7","author":"Zhao","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.08.024_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbalip.2014.12.005","article-title":"Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis","volume":"1851","author":"Schackmann","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.08.024_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jb\/mvs105","article-title":"Very long-chain fatty acids: elongation, physiology and related disorders","volume":"152","author":"Kihara","year":"2012","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymthe.2026.08.024_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/JVI.01990-14","article-title":"Insight into the mechanism of inhibition of adeno-associated virus by the Mre11\/Rad50\/Nbs1 complex","volume":"89","author":"Lentz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib38","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1128\/JVI.00171-15","article-title":"Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1","volume":"89","author":"Millet","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3049","article-title":"Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle","volume":"20","author":"Zhu","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.08.024_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051259","article-title":"Knockout of the CMP-Sialic Acid Transporter SLC35A1 in Human Cell Lines Increases Transduction Efficiency of Adeno-Associated Virus 9: Implications for Gene Therapy Potency Assays","volume":"10","author":"Banning","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.08.024_bib41","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1016\/j.cell.2024.06.024","article-title":"The WDR11 complex is a receptor for acidic-cluster-containing cargo proteins","volume":"187","author":"Deng","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.024_bib42","doi-asserted-by":"crossref","first-page":"12936","DOI":"10.1128\/JVI.01523-07","article-title":"The Mre11\/Rad50\/Nbs1 complex limits adeno-associated virus transduction and replication","volume":"81","author":"Schwartz","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1170","article-title":"Degradation and stable maintenance of adeno-associated virus inverted terminal repeats in E. coli","volume":"53","author":"Radukic","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.024_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01948-22","article-title":"Genome-Scale Analysis of Cellular Restriction Factors That Inhibit Transgene Expression from Adeno-Associated Virus Vectors","volume":"97","author":"Ngo","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001266","article-title":"Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus","volume":"7","author":"Reichelt","year":"2011","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.08.024_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib47","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.08.024_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102437","article-title":"Development, opportunities, and challenges of siRNA nucleic acid drugs","volume":"36","author":"Xiao","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.08.024_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0192623318792537","article-title":"The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies","volume":"46","author":"Janas","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib50","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ymthe.2025.03.064","article-title":"AAV vector development, back to the future","volume":"33","author":"Suarez-Amaran","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.08.024_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib54","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.ymthe.2024.11.012","article-title":"The rise of cochlear gene therapy","volume":"33","author":"Landegger","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11596-025-00084-6","article-title":"Advances and Challenges in Adeno-Associated Virus Gene Therapy Applications of Localized Delivery Strategies","volume":"45","author":"Chen","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.ymthe.2026.08.024_bib56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ajo.2025.07.025","article-title":"Ocular Delivery of Viral Vectors for Retinal and Choroidal Vascular Diseases: A Review","volume":"279","author":"Agrawal","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14712598.2024.2386339","article-title":"Intraparenchymal delivery of adeno-associated virus vectors for the gene therapy of neurological diseases","volume":"24","author":"Kumagai","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/14712598.2018.1416089","article-title":"AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials","volume":"18","author":"Hardcastle","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101522","article-title":"Directed evolution of novel AAV variants using the MCMS library for enhanced CNS tropism and reduced liver targeting in mice","volume":"33","author":"Song","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.024_bib60","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tig.2021.03.001","article-title":"Nonhomologous end joining: new accessory factors fine tune the machinery","volume":"37","author":"Ghosh","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2026.08.024_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JHD-210476","article-title":"Identification of Full-Length Wild-Type and Mutant Huntingtin Interacting Proteins by Crosslinking Immunoprecipitation in Mice Brain Cortex","volume":"10","author":"Sap","year":"2021","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.ymthe.2026.08.024_bib62","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.08.024_bib63","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1016\/j.cell.2025.06.026","article-title":"An alternate receptor for adeno-associated viruses","volume":"188","author":"Dhungel","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.024_bib64","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ymthe.2024.02.002","article-title":"High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury","volume":"32","author":"Hordeaux","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib65","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.ymthe.2023.07.020","article-title":"Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery","volume":"31","author":"Hudry","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.024_bib66","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/01926233231201408","article-title":"An Overview of Nonclinical and Clinical Liver Toxicity Associated With AAV Gene Therapy","volume":"51","author":"Whiteley","year":"2023","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib67","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"Chand","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib68","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.024_bib69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-422X-10-74","article-title":"A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype","volume":"10","author":"Ellis","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2026.08.024_bib70","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of Adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.08.024_bib72","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:36:22Z","timestamp":1788262582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"alternative-id":["S1525001626007057"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.024","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}